ACTIVATED CLOTTING TIME (ACT) - blood
Specimen: Freshly
drawn venous blood without anticoagulant; volume as specified for instrument in use.
Blood added immediately to instrument cartridge.
Method: Modified APTT. Several instruments are marketed as suitable for “bedside”
monitoring of heparin therapy.
Reference Interval: As specified by manufacturer. See Interpretation.
Application: Limited application in the acute monitoring of
heparin therapy
during cardiopulmonary surgery and in intensive care and dialysis units. Available
methods have variable and limited correlation with the APTT and may be influenced
by other variables (eg PCV and fibrinogen). A specific instrument should only
be selected for use if its performance has been validated against the methods used
in the pathology laboratory; correlation with the APTT and plasma heparin levels
should be checked at regular intervals.
Interpretation: The prolongation of the ACT above baseline is used as a rough
guide to the degree of heparinisation and, at times, the appropriate dose of protamine
sulphate. A more precise correlation would require prior characterisation of performance
by the pathology laboratory, including testing samples with known levels of plasma
heparin.
Reference: O'Neill AI et al. Anaesth Intensive Care 1991; 19: 592-601.